EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Increased cortical excitability to transcranial magnetic stimulation at the brain-tumor interface of IDH1 -mutant gliomas

Alexia Stark, Mykola Gorbachuk, Kathrin Machetanz, Maria Teresa Leao, Marina Liebsch, Sophie Wang, Jürgen Honegger, Marcos Tatagiba iD, Georgios Naros iD

Neuro-Oncology Advances · 12.01.2026 · 8 (1)

DOI: 10.1093/noajnl/vdag071 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuro-Oncology Advances, online erschienen am 15.03.2026. Verfasst von Alexia Stark und 8 weiteren Autor:innen. Beteiligte Einrichtung: Neurosurgical Clinic, Department of Neurosurgery and Neurotechnology, Eberhard Karls University, Tuebingen, Germany. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Open Access Publication Fund of the University of Tübingen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

There is increasing interest in the glioma-to-neuro communication at the brain-tumor interface (BTI). In vitro studies indicate that gliomas with a mutation of the isocitrate dehydrogenase (IDH) increase neuronal excitability of the peritumoral cortex, contributing to epileptogenesis in these patients. However, in vivo evidence is missing. This study evaluates the electric characteristics of the BTI relative to the IDH mutation status.

Methods

To investigate peritumoral cortical excitability (CE), we applied 5258 pulses of transcranial magnetic stimulation (TMS) at the BTI of IDH-mutant (IDH-mt) and IDH-wildtype (IDH-wt) glial tumors in 39 patients. Cortical excitability was assessed by the resting motor threshold (RMT) and the synchronized electromyographic (EMG) activity (ie, event-related spectral perturbation, ERSP) after TMS. The ERSP values were related to the IDH status, tumor grading, antiepileptic drug (AED) intake, and the spatial relationship to the tumor borders.

Results

Within our sample, there was no significant group difference in RMT. The TMS to the BTI triggered an EMG synchronization decreasing linearly with the distance to the functional hotspot. In contrast, IDH-mt gliomas demonstrated an increased cortical output of the peritumoral brain tissue compared with IDH-wt gliomas. This effect was not attributable to AED intake or other histological and molecular characteristics. Notably, cortical hyperexcitability was detectable well beyond the tumor border.

Conclusions

This study provides in vivo evidence of cortical hyperexcitability at the BTI of IDH-mt gliomas. The data demonstrate how molecular glioma characteristics affect peritumoral neuronal circuits. Modulating interactions at the BTI might pave the way for novel therapies.

Schlagwörter

Stichwörter der Autor:innen

brain-tumor interfaceepileptogenesisgliomaisocitrate dehydrogenasetranscranial magnetic stimulation

Autor:innen und Institutionen

  • Neurosurgical Clinic, Department of Neurosurgery and Neurotechnology, Eberhard Karls University, Tuebingen, Germany.

ORCID-Profile: Marcos Tatagiba, Georgios Naros

Förderung

  • Open Access Publication Fund of the University of Tübingen

Zitieren

APA

Stark, A., Gorbachuk, M., Machetanz, K., Leao, M. T., Liebsch, M., Wang, S., Honegger, J., Tatagiba, M., & Naros, G. (2026). Increased cortical excitability to transcranial magnetic stimulation at the brain-tumor interface of IDH1 -mutant gliomas. Neuro-Oncology Advances, 8(1). https://doi.org/10.1093/noajnl/vdag071

Vancouver

Stark A, Gorbachuk M, Machetanz K, Leao MT, Liebsch M, Wang S, et al. Increased cortical excitability to transcranial magnetic stimulation at the brain-tumor interface of IDH1 -mutant gliomas. Neuro-Oncology Advances. 2026;8(1). doi:10.1093/noajnl/vdag071

BibTeX
@article{Stark2026,
  author = {Stark, Alexia and Gorbachuk, Mykola and Machetanz, Kathrin and Leao, Maria Teresa and Liebsch, Marina and Wang, Sophie and Honegger, Jürgen and Tatagiba, Marcos and Naros, Georgios},
  title = {Increased cortical excitability to transcranial magnetic stimulation at the brain-tumor interface of IDH1 -mutant gliomas},
  journal = {Neuro-Oncology Advances},
  year = {2026},
  volume = {8},
  number = {1},
  doi = {10.1093/noajnl/vdag071}
}
Kostenlos starten →